A 58-year-old male presented with blurring of vision and floaters in the right eye (OD) since 1 month. His best-corrected visual acuity was 20/20, N6 OD and 20/20, N6 left eye (OS). He was a known case of type II diabetes mellitus under oral hypoglycemic agents with controlled sugar levels. He gave history of 9 kg weight loss in the past 2 months and an episode of fever 2 months ago. His anterior segment examination was normal in both the eyes. Fundus examination showed presence of bilateral multiple retinal hemorrhages, Roth spots, perivascular sheathing, and retinal infiltrates with vitreous haemorrhage in the right eye [ Figs. 1 and 2 ]. With differential diagnosis of infectious retinal vasculitis, occlusive vascular retinopathy, and masquerades, fundus fluorescein angiography (FFA) and systemic work up were advised. FFA revealed bilateral multiple hyperfluorescent dots, leakage suggestive of neovascularization of the disc and elsewhere, multiple capillary nonperfusion areas [Figs. 3 and 4] , and a peculiar bumpy appearance of vessels similar to a "string of beads" [Fig. 5] . This appearance of vessels was seen in arteries, arterioles, and capillaries but was most prominent in capillaries. On systemic work up, the patient was found to have leucocytosis (2,085,000/µL), erythrocyte sedimentation rate of 34 mm/h, C-reactive protein positive, and presence of myeloblasts and immature granulocytes on peripheral smear. Mantoux test, treponema pallidum haemagglutination assay, HIV-1 and 2, and polymerase chain reaction for common viral genomes were negative. In view of leukocytosis, bone marrow biopsy was done, which revealed presence of Philadelphia translocation "t(9;22)(q34;q11)." He was diagnosed to have chronic myeloid leukemia (CML; chronic phase). The patient was subjected to laser pan-retinal photocoagulation and This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. CML is a clonal myeloproliferative disorder of hematopoietic stem cells. Bilateral proliferative retinopathy as an initial presentation of CML has been described previously. [1] [2] [3] [4] [5] The "string of beads" term has been used to describe the radiological appearance of vessels in fibromuscular dysplasia [6] and as a radiological sign in small bowel obstruction. [7] In ophthalmology, the term has been used to describe the appearance of vitreous opacities in Candida endophthalmitis. [8] However, the term has not been used to describe the appearance of vessels on FFA yet. CML with leukocytosis leading to hyperviscosity may be an explanation for this particular appearance of vessels. This could be an important diagnostic imaging clue on FFA in cases of proliferative retinopathy secondary to leukemia. However, larger case series is required to confirm this observation.
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There are no conflicts of interest. ), procarbazine, and vincristine). [1] Her visual acuity was 20/50 in the right eye (OD) and counting fingers at 1 m OS. Examination revealed vitritis in OD and a large, hazy indistinct yellowish submacular lesion in OS [ Fig. 1 ]. Fluorescein angiography (FA) showed diffuse hyperfluorescence in the macular region in the late phase. Swept-source optical coherence tomography (SS-OCT) revealed a uniform, subretinal hyper-reflective band above the retinal pigment epithelium (RPE). The patient received intravitreal methotrexate 400 µg/0.1 mL and was asked to continue further cycles of systemic chemotherapy. [2] Intravitreal
